This Ontario act monitors drugs that can cause risks in public.
Monitored Drugs List (PDF)
The Narcotics Safety and Awareness Act, 2010 (“Act”) seeks to improve the health and safety of Ontarians by promoting appropriate prescribing and dispensing practices for narcotics and other controlled substances, identifying and reducing the abuse, misuse and diversion of these drugs and reducing the risk of addiction and death from the abuse or misuse of these drugs. The Act will come into force on November 1, 2011.
The Narcotics Safety and Awareness Act, 2010 and its requirements apply to a list of prescription medications called monitored drugs. Monitored drugs are defined as follows:
- Any controlled substance under the federal Controlled Drugs and Substances Act. Examples of these include narcotic analgesics (e.g. Tylenol 3®, OxyNEO™), and non-narcotic controlled drugs such as methylphenidate (e.g. Ritalin®), benzodiazepines (e.g. Valium®), and barbiturates (e.g. phenobarbital).
For the complete list of controlled substances under the Controlled Drugs and Substances Act (Canada).
Learn more >>AND
- Other opioid medications not listed in the Controlled Drugs and Substances Act. This consists of tramadol containing products (Ralivia®, Tramacet®, Apo-tramadol/acetaminophen®, Tridural®, Ultram®, Zytram XL®) and tapentadol (Nucynta®).
For the authoritative text of the law:
- Regulation under the Narcotics Safety and Awareness Act, 2010
- Narcotics Safety and Awareness Act, 2010
- Feb 5, 2013 – Full Document: HTMLFull Document: Controlled Drugs and Substances Act
Regulations made under this Act
- Benzodiazepines and Other Targeted Substances Regulations
- Controlled Drugs and Substances Act (Police Enforcement) Regulations
- Industrial Hemp Regulations
- Marihuana Medical Access Regulations
- Narcotic Control Regulations
- New Classes of Practitioners Regulations
- Precursor Control Regulations
- Qualifications for Designations as Analysts Regulations
- Regulations Exempting Certain Precursors and Controlled Substances from the Application of the Controlled Drugs and Substances Act